FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2079268907> ?p ?o ?g. }

• W2079268907 endingPage "567" @default.
• W2079268907 startingPage "564" @default.
• W2079268907 abstract "We have previously shown that a short course of recombinant interferon-alpha-2b (rIFN-alpha-2b) (3 million units day for 5 days) for patients with primary gynaecologic malignancies was able to increase the circulating levels of a newly discovered tumour associated antigen, termed 90K. In this study, we have investigated the effects of the same modality of administration of rIFN-alpha-2b in 62 patients with breast and colorectal cancer whose primary tumour was surgically removed 1 month before and who were without evidence of disease (NED) at the time of the study. A significant increase of 90K serum concentration was already observed 24 h after the first r-IFN-alpha-2b injection and persisted throughout the investigational period. The increase was more pronounced in patients with a basal 90K-negative than a 90K-positive assay. Of 54 patients who started the test with a 90K negative assay, 17 (31%) shifted to a positive assay after rIFN-alpha-2b. Twenty-eight of 62 (45%) patients exhibited a 90K value above the mean increment of the whole population. The serum levels of CEA, CA-15-3, CA 19-9, and alpha-fetoprotein measured in the same serum samples were not modified. After 2 years of follow-up, ten patients relapsed. Six of them showed a 90K increase above the mean increment of the whole population. As with ovarian cancer, the increase of 90K following r-IFN-alpha-2b administration might be of importance for the early detection of disease recurrence in clinically NED breast and colon cancer patients." @default.
• W2079268907 created "2016-06-24" @default.
• W2079268907 creator A5015464334 @default.
• W2079268907 creator A5025670261 @default.
• W2079268907 creator A5027075905 @default.
• W2079268907 creator A5029630690 @default.
• W2079268907 creator A5046997933 @default.
• W2079268907 creator A5051575576 @default.
• W2079268907 creator A5054986896 @default.
• W2079268907 creator A5060428508 @default.
• W2079268907 date "1993-03-01" @default.
• W2079268907 modified "2023-10-06" @default.
• W2079268907 title "Dynamic test with recombinant interferon-alpha-2b: effect on 90K and other tumour-associated antigens in cancer patients without evidence of disease" @default.
• W2079268907 cites W1014366764 @default.
• W2079268907 cites W1487633847 @default.
• W2079268907 cites W1545474462 @default.
• W2079268907 cites W1561727589 @default.
• W2079268907 cites W1572314647 @default.
• W2079268907 cites W1903104346 @default.
• W2079268907 cites W1965752877 @default.
• W2079268907 cites W1966248662 @default.
• W2079268907 cites W1997169065 @default.
• W2079268907 cites W2015137936 @default.
• W2079268907 cites W2076085848 @default.
• W2079268907 cites W2081543802 @default.
• W2079268907 cites W2082018780 @default.
• W2079268907 cites W2088631258 @default.
• W2079268907 cites W2126645712 @default.
• W2079268907 cites W2143372682 @default.
• W2079268907 cites W2150612230 @default.
• W2079268907 cites W2168081054 @default.
• W2079268907 cites W2316461382 @default.
• W2079268907 cites W2419021665 @default.
• W2079268907 cites W4285719527 @default.
• W2079268907 doi "https://doi.org/10.1038/bjc.1993.103" @default.
• W2079268907 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1968249" @default.
• W2079268907 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8439505" @default.
• W2079268907 hasPublicationYear "1993" @default.
• W2079268907 type Work @default.
• W2079268907 sameAs 2079268907 @default.
• W2079268907 citedByCount "23" @default.
• W2079268907 countsByYear W20792689072013 @default.
• W2079268907 countsByYear W20792689072015 @default.
• W2079268907 countsByYear W20792689072021 @default.
• W2079268907 crossrefType "journal-article" @default.
• W2079268907 hasAuthorship W2079268907A5015464334 @default.
• W2079268907 hasAuthorship W2079268907A5025670261 @default.
• W2079268907 hasAuthorship W2079268907A5027075905 @default.
• W2079268907 hasAuthorship W2079268907A5029630690 @default.
• W2079268907 hasAuthorship W2079268907A5046997933 @default.
• W2079268907 hasAuthorship W2079268907A5051575576 @default.
• W2079268907 hasAuthorship W2079268907A5054986896 @default.
• W2079268907 hasAuthorship W2079268907A5060428508 @default.
• W2079268907 hasBestOaLocation W20792689072 @default.
• W2079268907 hasConcept C104317684 @default.
• W2079268907 hasConcept C121608353 @default.
• W2079268907 hasConcept C126322002 @default.
• W2079268907 hasConcept C141071460 @default.
• W2079268907 hasConcept C147483822 @default.
• W2079268907 hasConcept C203014093 @default.
• W2079268907 hasConcept C2775944032 @default.
• W2079268907 hasConcept C2776178377 @default.
• W2079268907 hasConcept C2778024521 @default.
• W2079268907 hasConcept C2779306644 @default.
• W2079268907 hasConcept C2780427987 @default.
• W2079268907 hasConcept C2908647359 @default.
• W2079268907 hasConcept C2909179924 @default.
• W2079268907 hasConcept C40767141 @default.
• W2079268907 hasConcept C49453240 @default.
• W2079268907 hasConcept C526805850 @default.
• W2079268907 hasConcept C55493867 @default.
• W2079268907 hasConcept C64943373 @default.
• W2079268907 hasConcept C71924100 @default.
• W2079268907 hasConcept C86803240 @default.
• W2079268907 hasConcept C90924648 @default.
• W2079268907 hasConcept C99454951 @default.
• W2079268907 hasConceptScore W2079268907C104317684 @default.
• W2079268907 hasConceptScore W2079268907C121608353 @default.
• W2079268907 hasConceptScore W2079268907C126322002 @default.
• W2079268907 hasConceptScore W2079268907C141071460 @default.
• W2079268907 hasConceptScore W2079268907C147483822 @default.
• W2079268907 hasConceptScore W2079268907C203014093 @default.
• W2079268907 hasConceptScore W2079268907C2775944032 @default.
• W2079268907 hasConceptScore W2079268907C2776178377 @default.
• W2079268907 hasConceptScore W2079268907C2778024521 @default.
• W2079268907 hasConceptScore W2079268907C2779306644 @default.
• W2079268907 hasConceptScore W2079268907C2780427987 @default.
• W2079268907 hasConceptScore W2079268907C2908647359 @default.
• W2079268907 hasConceptScore W2079268907C2909179924 @default.
• W2079268907 hasConceptScore W2079268907C40767141 @default.
• W2079268907 hasConceptScore W2079268907C49453240 @default.
• W2079268907 hasConceptScore W2079268907C526805850 @default.
• W2079268907 hasConceptScore W2079268907C55493867 @default.
• W2079268907 hasConceptScore W2079268907C64943373 @default.
• W2079268907 hasConceptScore W2079268907C71924100 @default.
• W2079268907 hasConceptScore W2079268907C86803240 @default.
• W2079268907 hasConceptScore W2079268907C90924648 @default.
• W2079268907 hasConceptScore W2079268907C99454951 @default.

• next